Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Non-Hodgkin's lymphoma

A Shad1, I Magrath

  • 1Division of Pediatric Hematology Oncology, Vincent T. Lombardi Cancer Center, Georgetown University Medical Center, Washington, DC, USA.

Pediatric Clinics of North America
|August 1, 1997
PubMed
Summary

Pediatric lymphomas, aggressive childhood cancers, show high survival rates with modern treatments. Understanding genetic changes aids diagnosis and targeted therapies for better outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Haemorrhage into juxta-facet cysts causing bilateral foot drop.

Journal of surgical case reports·2014
Same author

NMO-IgG positive relapsing longitudinally extensive transverse myelitis (LETM) in a seropositive HIV patient.

Clinical neurology and neurosurgery·2013
Same author

Denis Burkitt and the African lymphoma.

Ecancermedicalscience·2012
Same author

Molecular characterization of scl rearrangements in T-cell all from India and egypt.

International journal of oncology·2011
Same author

Prognostic-significance of p53 mutations in small non-cleaved cell lymphomas.

International journal of oncology·2011
Same author

Childhood T-lineage acute lymphoblastic leukemia: management and outcome at a tertiary care center in North India.

Indian pediatrics·2011

Area of Science:

  • Pediatric Oncology
  • Hematology
  • Molecular Biology

Background:

  • Pediatric lymphomas are aggressive malignancies in children and adolescents.
  • They differ from adult lymphomas in their diffuse nature and tendency for widespread dissemination.
  • Despite aggressiveness, survival rates have significantly improved.

Purpose of the Study:

  • To summarize the current understanding of pediatric lymphomas.
  • To highlight advancements in treatment and supportive care.
  • To emphasize the role of molecular abnormalities in diagnosis and future therapies.

Main Methods:

  • Review of current literature on pediatric lymphomas.
  • Analysis of treatment outcomes for B-cell and T-cell lymphomas.
  • Discussion of molecular pathogenesis and its clinical implications.

Main Results:

  • Event-free survival rates approach 90% for pediatric B-cell lymphomas and are only slightly lower for T-cell lymphomas.
  • Genetic alterations are fundamental to the development of lymphoid neoplasms.
  • Molecular characterization enables improved diagnostics and minimal residual disease detection.

Conclusions:

  • Intensified treatment and supportive care have dramatically improved survival for pediatric lymphomas.
  • Understanding molecular abnormalities is crucial for developing targeted therapies.
  • Future research will focus on novel treatments based on specific neoplastic cell characteristics.

Related Experiment Videos